CREATE MEDIC CO.,LTD.

Contact

About Create Medic

Financial Highlights

Net Sales

Net Sales by Sales Format

Ordinary Income

Net Income

Business Results Data (Cons.)

Unit:million yen

    
  FY 2021 FY 2022 FY 2023 FY 2024 FY 2025(Est.)
Net Sales 11,698 12,326 12,585 13,030 13,583

Cost of Sales
(% of Net Sales)

6,438
55.0%
6,931
56.2%
7,107
56.5%
7,326
56.2%
7,577
55.8%

Gross Profit
(% of Net Sales)

5,260
45.0%
5,395
43.8%
5,478
43.5%
5,704
43.8%
6,006
44.2%

SG&A expenses
(% of Net Sales)

4,393
37.6%
4,654
37.8%
4,675
37.1%
5,011
38.5%
5,004
36.8%

Operating Income 
(% of Net Sales)

866
7.4%
741
6.0%
803
6.4%
692
5.3%
1,002
7.4%

Ordinary Income 
(% of Net Sales)

1,009
8.6%
834
6.8%
872
6.9%
750
5.8%
1,043
7.7%

Net Income
(% of Net Sales)

660
5.6%
482
3.9%
154
1.2%
840
6.5%
796
5.9%

Net Sales by Sales Format(cons.)

Unit:million yen

 
  FY 2021 FY 2022 FY 2023 FY 2024 FY 2025(Est.)

Own-brand
(%)

6,884
58.8%
6,986
56.7%
6,920
55.0%
7,182
55.1%
7,530
55.4%
Overseas
(%)
3,493
29.9%
4,000
32.5%
4,257
33.8%
4,608
35.4%
4,719
34.7%
OEM Sales
(%)
1,320
11.3%
1,340
10.9%
1,407
11.2%
1,239
9.5%
1,334
9.8%
Total
(%)
11,698
100.0%
12,326
100.0%
12,585
100.0%
13,030
100.0%
13,583
100.0%

Graph Showing Financial Position

Free Cash Flow

Financial Position Data(cons.)

Unit:million yen

  
  FY 2021 FY 2022 FY 2023 FY 2024 FY 2025(Est.)

Current Assets

11,575 12,128 12,722 13,940 14,807

Fixed Assets

6,500 6,736 6,535 6,107 5,051

Total Assets
(Gross Assets)

18,075 18,865 19,258 20,047 19,857

Current Liabilities

2,573 2,816 2,967 3,105 2,915

Fixed Liabilities

1,282 1,325 1,347 1,191 984

Total Liabilities

3,855 4,141 4,314 4,296 3,899

Shareholders' Equity

14,220 14,723 14,944 15,750 15,958

Equity Ratio

78.7% 78.0% 77.6% 78.6% 80.4%

Cash Flow Data

Unit:million yen

  FY 2021 FY 2022 FY 2023 FY 2024 FY 2025
(Est.)

Net cash provided by (used in) operating activities

1,248 478 698 2,249 818

Net cash provided by (used in) investing activities

△ 585 43 △ 363 270 △ 167

Net cash provided by (used in) financing activities

△ 442 △ 356 △ 362 △ 877 △ 365

Net increase in cash and cash equivalents

330 288 68 1,891 386

Cash and cash equivalents at end of year

3,413 3,702 3,770 5,662 5,602

Free Cash Flow

663 522 335 2,520 651
  • NOTE 1) Figures are shown on a consolidated basis.
  • NOTE 2) Figures are shown rounded down to the nearest million yen.
  • NOTE 3) Free Cash Flow is represented as the total of CF from operating activities + CF from investment activities.

Investment index

  FY 2021 FY 2022 FY 2023 FY 2024 FY 2025(Est.)
ROE 4.8% 3.3% 1.0% 5.5% 5.0%
EPS(yen) 72.61 53.00 16.92 95.41 92.67
BPS(yen) 1,563.55 1,618.10 1,641.59 1,833.67 1,857.81

Dividend per Share (yen)

37 37 37 39 37

Dividend Payout Ratio(cons.)

51.0% 69.8% 218.7% 40.9% 39.9%

TOP